소변 유량계 시장 : 규모, 점유율, 성장, 업계 분석, 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of urinary flow meters Market

The global urinary flow meters market was valued at USD 23.2 million in 2025 and is projected to grow to USD 25.1 million in 2026. The market is expected to reach USD 50.1 million by 2034, registering a CAGR of 9% during 2026-2034. North America dominated the global market in 2025, accounting for 39.5% of total revenue.

Urinary flow meters, also known as uroflowmeters, are diagnostic devices used to measure the rate and volume of urine flow. These systems assist in diagnosing urinary tract disorders such as benign prostatic hyperplasia (BPH), urinary incontinence, urine retention, bladder cancer, and prostate cancer. Their ease of use, improved handling, accurate measurement capabilities, and integration with digital systems have significantly increased adoption across hospitals and specialty clinics.

Market Dynamics

Market Drivers

Rising Prevalence of Urological Disorders

The increasing global burden of urinary tract disorders is a major factor driving market growth. Conditions such as BPH, stress urinary incontinence (SUI), bladder obstruction, and prostate cancer are becoming more common, particularly among aging populations. For instance, studies indicate high prevalence of SUI among women in countries such as China, significantly boosting demand for uroflowmetry testing.

Growing Geriatric Population

The global elderly population continues to rise, increasing susceptibility to urinary dysfunction. Age-related bladder issues and prostate enlargement significantly contribute to demand for diagnostic devices. Europe, where more than one-fifth of the population is aged 65 and above, represents a strong growth region due to this demographic shift.

Technological Advancements and Product Launches

Manufacturers are increasingly launching advanced PC-based urinary flow meters that integrate with Electronic Medical Records (EMRs), offer enhanced accuracy, and support digital diagnostics. These innovations are strengthening adoption across technologically advanced healthcare settings.

COVID-19 Impact

The COVID-19 pandemic negatively affected market revenues due to reduced patient visits and reallocation of hospital resources toward pandemic care. Urology departments experienced reduced bed occupancy and outpatient visits. However, with the resumption of surgical procedures and diagnostic visits in 2021 and 2022, the market gradually returned to pre-pandemic growth levels, supporting steady expansion from 2025 onward.

Market Trends

Transition from Non-PC Based to PC-Based Devices

A key market trend is the increasing shift toward PC-based urinary flow meters. These systems provide:

• Higher precision in urine flow measurement
• Seamless EMR integration
• Efficient patient data management
• Improved clinical decision-making

As healthcare systems continue digitization, demand for PC-based devices is expected to remain strong throughout the forecast period.

Market Restraints

Despite strong growth prospects, certain factors may hinder expansion:

• High device costs, particularly for advanced models
• Limited awareness in developing economies
• Lower healthcare expenditure in emerging countries

These factors reduce adoption rates in price-sensitive regions.

Segmentation Analysis

By Type

The market is segmented into PC-Based and Non-PC Based urinary flow meters.

• The PC-Based segment held the largest share of 57.77% in 2025 and is expected to register the fastest growth through 2034. Growth is supported by increasing disease prevalence and demand in developed healthcare systems.
• The Non-PC Based segment is projected to grow steadily, supported by demand for cost-effective and standalone diagnostic solutions.

By End-User

The market is categorized into hospitals, specialty clinics, and others.

• Hospitals dominated the market in 2025, accounting for 47.41% share, due to higher patient volumes and availability of advanced diagnostic infrastructure.
• Specialty clinics are expected to witness the fastest growth during the forecast period, driven by the rising number of independent urology clinics and growing uroflowmetry testing procedures.

Regional Insights

North America

North America generated USD 9.2 million in 2025, maintaining its leadership with a 39.5% market share. Growth is driven by high adoption of PC-based devices, strong healthcare infrastructure, and rising prevalence of prostate and bladder cancers. The region continues to see new product launches and digital diagnostic initiatives.

Europe

Europe held a substantial market share and is projected to grow steadily through 2034. Rising geriatric population and high prevalence of bladder cancer support regional expansion. Established players and well-developed healthcare systems further strengthen the market.

Asia Pacific

Asia Pacific is expected to register the highest CAGR during the forecast period. Rapid aging populations, increasing awareness of urinary health, and growing healthcare investments in countries such as Japan, China, and India are driving regional demand.

Rest of the World

Markets in Latin America, the Middle East, and Africa are growing due to improving healthcare infrastructure and rising diagnosis rates of urological conditions.

Competitive Landscape

Key players operating in the global urinary flow meters market include:

• MINZE HEALTH
• Oruba Technology & Innovation
• tic Medizintechnik GmbH & Co. KG
• Potent Medical
• Laborie
• Apex MediTech
• Status Medical Equipments India Pvt Limited
• Medica S.p.A

Companies are focusing on mergers, acquisitions, regulatory approvals, and product innovations to strengthen their global footprint.

Conclusion

The global urinary flow meters market demonstrates strong growth potential, increasing from USD 23.2 million in 2025 to USD 25.1 million in 2026, and projected to reach USD 50.1 million by 2034, at a 9% CAGR. Rising prevalence of urological disorders, expanding geriatric population, technological advancements, and growing digital integration in healthcare are key growth drivers. While high costs and limited awareness in developing regions may pose challenges, increasing innovation and expanding diagnostic infrastructure are expected to sustain long-term market expansion worldwide.

Segmentation By Type

• PC Based Urinary Flow Meters
• Non-PC Based Urinary Flow Meters

By End-user

• Hospitals
• Specialty Clinics
• Others

By Geography

• North America (By Type, By End-user, and By Country)
  • U.S.
  • Canada
• Europe (By Type, By End-user, and By Country/Sub-region)
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific (By Type, By End-user, and By Country/Sub-region)
  • Japan
  • China
  • India
  • Australia
  • Rest of Asia Pacific
• Rest of the World (By Type, By End-user)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trend

4. Key Insights

• 4.1. Epidemiology of Key Diseases/Conditions, By Key Countries/Region
• 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships & New Product Launches)
• 4.3. Technological Advancements in the Urinary Flow Meters
• 4.4. Impact of COVID-19 on the Market

5. Global Urinary Flow Meters Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Type
  • 5.1.1. Standalone Urine Flow Meter
  • 5.1.2. PC based Urine Flow Meter
• 5.2. Market Analysis, Insights and Forecast - By End-user
  • 5.2.1. Hospitals
  • 5.2.2. Specialty Clinics
  • 5.2.3. Others
• 5.3. Market Analysis, Insights and Forecast - By Region
  • 5.3.1. North America
  • 5.3.2. Europe
  • 5.3.3. Asia Pacific
  • 5.3.4. Rest of the World

6. North America Urinary Flow Meters Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Type
  • 6.1.1. Standalone Urine Flow Meter
  • 6.1.2. PC based Urine Flow Meter
• 6.2. Market Analysis, Insights and Forecast - By End-user
  • 6.2.1. Hospitals
  • 6.2.2. Specialty Clinics
  • 6.2.3. Others
• 6.3. Market Analysis, Insights and Forecast - By Country
  • 6.3.1. U.S.
  • 6.3.2. Canada

7. Europe Urinary Flow Meters Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Type
  • 7.1.1. Standalone Urine Flow Meter
  • 7.1.2. PC based Urine Flow Meter
• 7.2. Market Analysis, Insights and Forecast - By End-user
  • 7.2.1. Hospitals
  • 7.2.2. Specialty Clinics
  • 7.2.3. Others
• 7.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.3.1. U.K.
  • 7.3.2. Germany
  • 7.3.3. France
  • 7.3.4. Spain
  • 7.3.5. Italy
  • 7.3.6. Rest of Europe

8. Asia Pacific Urinary Flow Meters Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Type
  • 8.1.1. Standalone Urine Flow Meter
  • 8.1.2. PC based Urine Flow Meter
• 8.2. Market Analysis, Insights and Forecast - By End-user
  • 8.2.1. Hospitals
  • 8.2.2. Specialty Clinics
  • 8.2.3. Others
• 8.3. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.3.1. Japan
  • 8.3.2. China
  • 8.3.3. India
  • 8.3.4. Australia
  • 8.3.5. Rest of Asia Pacific

9. Rest of the World Urinary Flow Meters Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Type
  • 9.1.1. Standalone Urine Flow Meter
  • 9.1.2. PC based Urine Flow Meter
• 9.2. Market Analysis, Insights and Forecast - By End-user
  • 9.2.1. Hospitals
  • 9.2.2. Specialty Clinics
  • 9.2.3. Others

10. Competitive Analysis

• 10.1. Global Market Share Analysis (2022)
• 10.2. Company Profiles
  • 10.2.1. MINZE HEALTH
    • 10.2.1.1. Overview
    • 10.2.1.2. Product
    • 10.2.1.3. SWOT Analysis
    • 10.2.1.4. Recent Developments
    • 10.2.1.5. Strategies
    • 10.2.1.6. Financials (Based on Availability)
  • 10.2.2. Oruba Technology & Innovation
    • 10.2.2.1. Overview
    • 10.2.2.2. Product
    • 10.2.2.3. SWOT Analysis
    • 10.2.2.4. Recent Developments
    • 10.2.2.5. Strategies
    • 10.2.2.6. Financials (Based on Availability)
  • 10.2.3. tic Medizintechnik GmbH & Co. KG
    • 10.2.3.1. Overview
    • 10.2.3.2. Product
    • 10.2.3.3. SWOT Analysis
    • 10.2.3.4. Recent Developments
    • 10.2.3.5. Strategies
    • 10.2.3.6. Financials (Based on Availability)
  • 10.2.4. Potent Medical
    • 10.2.4.1. Overview
    • 10.2.4.2. Product
    • 10.2.4.3. SWOT Analysis
    • 10.2.4.4. Recent Developments
    • 10.2.4.5. Strategies
    • 10.2.4.6. Financials (Based on Availability)
  • 10.2.5. Laborie
    • 10.2.5.1. Overview
    • 10.2.5.2. Product
    • 10.2.5.3. SWOT Analysis
    • 10.2.5.4. Recent Developments
    • 10.2.5.5. Strategies
    • 10.2.5.6. Financials (Based on Availability)
  • 10.2.6. Apex MediTech
    • 10.2.6.1. Overview
    • 10.2.6.2. Product
    • 10.2.6.3. SWOT Analysis
    • 10.2.6.4. Recent Developments
    • 10.2.6.5. Strategies
    • 10.2.6.6. Financials (Based on Availability)
  • 10.2.7. Status Medical Equipments India Pvt Limited
    • 10.2.7.1. Overview
    • 10.2.7.2. Product
    • 10.2.7.3. SWOT Analysis
    • 10.2.7.4. Recent Developments
    • 10.2.7.5. Strategies
    • 10.2.7.6. Financials (Based on Availability)
  • 10.2.8. Medica S.p.A
    • 10.2.8.1. Overview
    • 10.2.8.2. Product
    • 10.2.8.3. SWOT Analysis
    • 10.2.8.4. Recent Developments
    • 10.2.8.5. Strategies
    • 10.2.8.6. Financials (Based on Availability)